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1. INTRODUCTION {#agm212044-sec-0001}
===============

Although neuroinflammation is a feature of Alzheimer\'s disease,[1](#agm212044-bib-0001){ref-type="ref"} the degree to which pathophysiology may be driven by systemic inflammation is unclear. For example, systemic illnesses with a pro‐inflammatory response may contribute to neurodegeneration and worsening dementia severity.[2](#agm212044-bib-0002){ref-type="ref"}, [3](#agm212044-bib-0003){ref-type="ref"}, [4](#agm212044-bib-0004){ref-type="ref"}, [5](#agm212044-bib-0005){ref-type="ref"} However, findings from epidemiological studies have been inconsistent[6](#agm212044-bib-0006){ref-type="ref"}, [7](#agm212044-bib-0007){ref-type="ref"}, [8](#agm212044-bib-0008){ref-type="ref"}, [9](#agm212044-bib-0009){ref-type="ref"}, [10](#agm212044-bib-0010){ref-type="ref"}, [11](#agm212044-bib-0011){ref-type="ref"}; discrepancies may in part reflect complexities in modelling the temporal patterns of modifiable life course factors on both systemic inflammation and cognition. These factors include educational attainment,[12](#agm212044-bib-0012){ref-type="ref"} body mass index (BMI),[13](#agm212044-bib-0013){ref-type="ref"} alcohol intake,[14](#agm212044-bib-0014){ref-type="ref"} smoking, and exercise.[15](#agm212044-bib-0015){ref-type="ref"} Many of these exposures are time‐varying and so apparent associations with inflammation and cognition may be subject to reverse causation.

In this study, we set out to quantify the relationships among measures of systemic inflammation, modifiable life course factors known to be associated with cognitive impairment, and subsequent cognitive outcomes. We investigated this in a birth cohort with the advantage of accurate ascertainments of exposures across the whole life course, along with detailed assessment of cognition, to answer the following questions:

Is systemic inflammation prospectively associated with later cognitive impairment?Is any association explained by modifiable lifestyle risk factors, such as early life educational attainment, body mass index, mid‐life exercise, alcohol consumption, or smoking?

2. METHODS {#agm212044-sec-0002}
==========

2.1. Population sample {#agm212044-sec-0003}
----------------------

The MRC National Survey for Health and Development (NSHD) is the oldest British birth cohort, following a sample of 5362 male and female participants born in 1 week in March 1946.[16](#agm212044-bib-0016){ref-type="ref"} During the 24th data collection in 2014‐2015, 2942 participants in the target sample living in England, Scotland, and Wales were contacted: 2453 (83.4%) returned a postal questionnaire and 2149 (73%) participants had a home visit by a research nurse.[17](#agm212044-bib-0017){ref-type="ref"} The target sample did not include participants no longer in the study (*n* = 2420): 957 (17.8% of the original sample) had already died, 620 (11.6%) had previously withdrawn from the study, 448 (8.3%) had emigrated and had no contact with the study, and 395 (7.4%) had been untraceable for more than 5 years.

2.2. Outcomes: General cognition {#agm212044-sec-0004}
--------------------------------

At age 69 years, the cognitive assessments comprised the Addenbrooke\'s Cognitive Examination, third version (ACE‐III), and verbal memory and visual search speed tasks, carried out by a research nurse according to the same standardized protocol as at earlier ages.[18](#agm212044-bib-0018){ref-type="ref"} A customized version of the ACE‐III was administered by iPad (Apple) using ACE Mobile (<http://www.acemobile.org/>). Of the 2149 participants visited by the research nurse, complete ACE‐III data were available for 1751 participants (81.5% of those who received a home visit).[17](#agm212044-bib-0017){ref-type="ref"} Verbal memory was assessed using a 15‐item word‐learning task, where each word was presented for 2 seconds. The score represents the total number of words correctly recalled over three identical trials (maximum 45). Visual search speed was assessed by crossing out the letters P and W, randomly embedded within a grid of other letters, as quickly and accurately as possible in 1 minute. The score represents the total number of letters searched (maximum 600).

2.3. Exposures: Serum inflammatory markers and covariates {#agm212044-sec-0005}
---------------------------------------------------------

At age 60‐64 years, participants had attended a clinic or had been visited by a research nurse, during which a blood sample had been taken. Aliquots were frozen and transferred to the MRC Human Nutrition Research Laboratory in Cambridge, UK, where analyses of inflammatory marker C‐reactive protein (CRP) and white blood cells were processed according to standardized protocols.[19](#agm212044-bib-0019){ref-type="ref"} Analyses of interleukin‐6 (IL‐6) were further undertaken by the British Heart Foundation Research Centre in Glasgow, UK.

During the home or clinic visits, waist circumference, height, and weight were measured using standardized protocols, and BMI was calculated (kg/m^2^). Participants were asked how many times in the last 4 weeks they had taken part in sports or vigorous activities, categorized as inactive (no episodes), less active (1‐4 exercise episodes/mo), and more active (≥5 exercise episodes/mo). Smoking history was prospectively self‐reported and calculated as pack‐years. Alcohol consumption was defined by frequency: four or more times per week; two to four times per week; two to four times per month; less than monthly; or a lifelong non‐drinker of alcohol. Educational qualifications by age 26 were categorized into none or less than ordinary secondary level ("O" levels usually taken at age 16); "O" levels; and advanced secondary level ("A" level) and higher. All data collected at age 60‐64 years were used to update corresponding information at earlier ages.

2.4. Statistical analysis {#agm212044-sec-0006}
-------------------------

The complete sample with cognitive assessments at 69 years, serum inflammatory markers at 60‐64 years, and complete information on covariates data included 1008 participants. CRP, IL‐6, and white cell count (WCC) were divided into tertiles, consistent with the previous literature.[6](#agm212044-bib-0006){ref-type="ref"} All cognitive measures and continuous covariates were assessed for Gaussian distributions. Using a complete sample, associations between inflammatory exposures and cognition were estimated using univariate linear regression, then in turn adjusted for each selected covariate. All covariates that resulted in a change in model estimates when adjusted for were included in a final regression model (Table [S1](#agm212044-sup-0001){ref-type="supplementary-material"}).

Linear regression was performed for all inflammation exposures and covariates with ACE‐III, then adjusted for educational attainment at age 26 years, then additionally adjusted for modifiable life course covariates. Similar models were estimated for visual search speed and verbal memory at 69 years, first adjusting for prior performance at 53 years, then additionally for educational attainment; and finally, additionally for modifiable life course covariates. STATA version 15.1 (StataCorp) was used for all analyses.

3. RESULTS {#agm212044-sec-0007}
==========

The prevalence of each exposure, including mean and standard deviations of inflammatory markers at age 60‐64 years, in relation to the sample followed at age 69 years is shown in Table [1](#agm212044-tbl-0001){ref-type="table"}. No significant sex differences were observed between each inflammation marker and individual covariates.

###### 

Characteristics for NSHD participants completing ACE‐III at 69 y

  Maximum sample with ACE‐III        NSHD age 60‐64 y                 
  ---------------------------------- ------------------ ------------- --------
  *n*                                841                910           
  ACE‐III at 69 y                    91.4 (5.64)        91.7 (6.13)   0.28
  Mean visual search speed (SD)                                       
  At 69 y                            256 (74)           268 (74)      \<0.01
  At 53 y                            273 (75)           289 (76)      \<0.01
  Mean verbal memory score (SD)                                       
  At 69 y                            21.1 (6.0)         23.2 (6.0)    \<0.01
  At 53 y                            23.0 (6.2)         24.8 (6.3)    \<0.01
  Education                                                           
  \<O levels                         34.2               37.1          
  O level                            14.5               25.9          
  ≥A levels                          51.3               36.9          \<0.01
  Body mass index (mean, SD)         27.9 (4.1)         27.9 (5.5)    0.94
  Exercise activity at 60‐64 y (%)                                    
  Never                              61.3               59.3          
  1‐4 times/wk                       14.5               15.6          
  ≥5 times/wk                        24.2               25.2          0.71
  Smoking (pack‐years) at 60‐64 y                                     
  Lifelong non‐smoker (%)            29.5               41.5          
  1‐5 pack‐years (%)                 17.3               20.9          
  6‐20 pack‐years (%)                28.2               19.8          
  \>20 pack‐years (%)                25.1               17.8          \<0.01
  Alcohol intake at 68 y                                              
  Never                              17.0               29.0          
  Less than monthly                  5.2                8.0           
  2‐4 times per month                13.1               17.9          
  2‐4 times per week                 28.1               22.9          
  4 or more times per week           36.6               22.3          \<0.01
  CRP (median, IQR)                  *n* = 685          *n* = 746     
  1.94 (0.78‐3.34)                   2.14 (1.3‐3.71)    0.55          
  IL‐6 (median, IQR)                 *n* = 680          *n* = 745     
  1.83 (1.26‐3.06)                   1.82 (1.27‐2.89)   0.78          
  WCC (median, IQR)                  *n* = 683          *n* = 749     
  5.9 (5.1‐7)                        5.6 (4.8‐6.7)      \<0.01        

ACE‐III, Addenbrooke\'s Cognitive Examination, third version; CRP, C‐reactive protein; IL‐6, interleukin‐6; IQR, interquartile range; NSHD, National Survey for Health and Development; SD, standard deviation; WCC, white cell count.
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3.1. Inflammation markers {#agm212044-sec-0008}
-------------------------

There was an association between CRP and IL‐6 with ACE‐III scores in univariate analyses (maximum coefficients compared to reference: CRP −1.29 points, IL‐6 −1.27 points; *P* \< 0.01). When adjusted for educational attainment, both associations were attenuated. Associations for all three inflammatory markers were further attenuated when fully adjusted for other modifiable life course factors (Table [2](#agm212044-tbl-0002){ref-type="table"}). No associations for CRP, IL‐6, and WCC with visual search speed or verbal memory were evident either in univariate or fully adjusted models (Tables [S2](#agm212044-sup-0002){ref-type="supplementary-material"} and [S3](#agm212044-sup-0002){ref-type="supplementary-material"}).

###### 

Linear regression analysis between ACE‐III at 69 y and serum inflammatory markers at 60‐64 y

  ACE‐III                           Univariate (complete)   Adjusted for educational attainment   Fully adjusted                                                                  
  --------------------------------- ----------------------- ------------------------------------- ---------------- -------- ------- ------- ------- ------ ------- ------- ------ --------
  CRP at 60‐64 y                                                                                                                                                                  
  1st tertile                       Ref.                                                                                    Ref.                           Ref.                   
  2nd tertile                       −0.72                   −1.55                                 0.11                      −0.43   −1.19   0.33           −0.29   −1.06   0.49   
  3rd tertile                       −1.26                   −2.10                                 −0.41            0.01     −0.46   −1.24   0.32    0.42   −0.10   −0.97   0.76   0.76
  IL‐6 at 60‐64 y                                                                                                                                                                 
  1st tertile                       Ref.                                                                                    Ref.                           Ref.                   
  2nd tertile                       −0.96                   −1.79                                 −0.14                     −0.84   −1.59   −0.08          −0.56   −1.34   0.22   
  3rd tertile                       −1.27                   −2.11                                 −0.42            \<0.01   −0.73   −1.51   0.04    0.06   −0.32   −1.23   0.58   0.37
  WCC at 60‐64 y                                                                                                                                                                  
  1st tertile                       Ref.                                                                                    Ref.                           Ref.                   
  2nd tertile                       −0.50                   −1.35                                 0.34             0.24     −0.24   −1.01   0.53           0.12    −0.66   0.90   
  3rd tertile                       −0.76                   −1.60                                 0.07             0.19     −0.28   −1.04   0.48    0.73   0.32    −0.52   1.15   0.75
  Educational attainment by 26 y                                                                                                                                                  
  \<O levels                        Ref.                                                                                                                   Ref.                   
  O levels                          3.98                    3.11                                  4.85                                                     3.60    2.72    4.49   
  ≥A levels                         5.20                    4.49                                  5.91             \<0.01                                  4.70    3.94    5.47   \<0.01
  Sex                               0.42                    −0.27                                 1.11             0.23     0.62    −0.01   1.26    0.05   0.72    0.07    1.37   0.03
  BMI at 60‐64 years (per SD)       −0.70                   −1.07                                 −0.32            \<0.01   −0.33   −0.68   0.02    0.06   −0.18   −0.55   0.20   0.35
  Exercise at 60‐64 y                                                                                                                                                             
  Never                             Ref.                                                                                    Ref.                           Ref.                   
  1‐4 times                         1.44                    0.44                                  2.44                      0.53    −0.39   1.46           0.38    −0.55   1.31   
  \>5 times                         2.08                    1.27                                  2.89             \<0.01   1.14    0.39    1.90    0.01   1.00    0.22    1.77   0.04
  Smoking (pack‐years) at 60‐64 y                                                                                                                                                 
  Lifelong non‐smoker               Ref.                                                                                    Ref.                           Ref.                   
  1‐5 pack‐years                    0.71                    −0.23                                 1.65                      0.83    −0.03   1.69           0.64    −0.23   1.51   
  6‐20 pack‐years                   −0.28                   −1.18                                 0.63                      0.28    −0.55   1.12           0.23    −0.62   1.09   
  \>20 pack‐years                   −1.80                   −2.76                                 −0.85            \<0.01   −0.41   −1.31   0.48    0.09   −0.35   −1.30   0.60   0.26
  Alcohol at 68 y                                                                                                                                                                 
  Never                             Ref.                                                                                    Ref.                           Ref.                   
  Less than monthly                 −0.31                   −1.86                                 1.25                      −0.87   −2.31   0.56           −0.95   −2.38   0.48   
  2‐4 times per month               1.40                    0.28                                  2.53                      0.55    −0.48   1.59           0.49    −0.55   1.53   
  2‐4 times per week                1.41                    0.42                                  2.40                      0.53    −0.39   1.44           0.42    −0.52   1.35   
  4 or more times per week          2.46                    1.52                                  3.40             \<0.01   1.12    0.23    2.00    0.03   1.09    0.18    2.01   0.03

ACE‐III, Addenbrooke\'s Cognitive Examination, third version; BMI, body mass index; CI, confidence interval; CRP, C‐reactive protein; IL‐6, interleukin‐6; WCC, white cell count.
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3.2. Education attainment and lifestyle risk factors {#agm212044-sec-0009}
----------------------------------------------------

Increased educational attainment, increased mid‐life exercise frequency, and lower mid‐life alcohol intake were prospectively associated with ACE‐III in fully adjusted models (fully adjusted: education 4.70 points \["A" level or higher vs less than "O" level, *P* \< 0.01\]; alcohol 1.1 points \[four times per week vs none, *P* = 0.03\]; and exercise 1.0 points \[more than five times per week vs never, *P* = 0.04\]). Increased BMI at 60‐64 years was associated with ACE‐III in univariate models (*P* \< 0.01) but this association attenuated in the fully adjusted model (*P* = 0.35; Table [2](#agm212044-tbl-0002){ref-type="table"}). No associations were demonstrated between education or modifiable life course factors with later‐life visual search speed performance in fully adjusted models (Table [S2](#agm212044-sup-0002){ref-type="supplementary-material"}). Educational attainment, exercise, alcohol intake, and smoking were associated with later life verbal memory performance in fully adjusted models (Table [S3](#agm212044-sup-0002){ref-type="supplementary-material"}).

4. DISCUSSION {#agm212044-sec-0010}
=============

Our findings demonstrated that associations between mid‐life baseline IL‐6 and CRP with later life cognitive impairment were explained by educational attainment and modifiable life course factors. Mid‐life exercise, alcohol intake, and educational attainment were prospectively associated with domain‐specific impairment in verbal memory but not visual search speed, independently of mid‐life inflammation. Taken together, the relationship between systemic inflammation and later life cognition may be mediated by, or share pathways with, modifiable life course factors.

The literature on systemic inflammation, modifiable life course factors, and cognitive impairment has been inconsistent: While raised serum proinflammatory markers were prospectively associated with poorer cognitive performance in the Rotterdam,[9](#agm212044-bib-0009){ref-type="ref"} Framingham,[8](#agm212044-bib-0008){ref-type="ref"} and American Health, Aging, Body Composition cohorts,[10](#agm212044-bib-0010){ref-type="ref"} no associations were found in Dutch,[7](#agm212044-bib-0007){ref-type="ref"} Swedish,[11](#agm212044-bib-0011){ref-type="ref"} or other US cohorts.[7](#agm212044-bib-0007){ref-type="ref"}, [20](#agm212044-bib-0020){ref-type="ref"}, [21](#agm212044-bib-0021){ref-type="ref"}, [22](#agm212044-bib-0022){ref-type="ref"} These discrepancies likely reflect differences in study protocols, cohort ages, secular period, ethnicities, and degree of adjustment by confounders.

Our findings are unique in the following respects: First, participants were in their seventh decade, younger than other cohorts and perhaps at a critical period for when dementia pathophysiology is being initiated.[23](#agm212044-bib-0023){ref-type="ref"} In addition, the ACE‐III is a more detailed cognitive measure compared with briefer tests used in other studies, such as the Mini‐Mental State Examination. Nonetheless, our findings are limited by having a small range of serum pro‐inflammatory markers. In common with other cohort studies, our results may be subject to residual confounding and are specific to the population and era under study. Due to sample attrition, some data were missing and not at random. However, although we were unable to account for this in our model estimates, previous analyses within the NSHD cohort have shown only small differences between included participants and those excluded due to missing data.[19](#agm212044-bib-0019){ref-type="ref"} Multiple imputation of covariates, which can be intrinsically problematic, would likely result in minimal changes to the model.[24](#agm212044-bib-0024){ref-type="ref"} Unavailable confounders may have additionally contributed to cognitive changes: these included unrecorded comorbidities, such as atrial fibrillation, as well as changes in lifestyle behaviors between the studied ages of 60‐64 and 69 years, during transition from employment to retirement. Lastly, we assumed that levels of systemic inflammation would correspond to central inflammation across the whole population. This is unlikely to be the case because factors like blood‐brain barrier permeability are likely to vary between individuals,[25](#agm212044-bib-0025){ref-type="ref"} and even subclinical neurodegeneration may lead to microglial priming and consequent exaggeration of central inflammation.[26](#agm212044-bib-0026){ref-type="ref"}

At least in NSHD, it appears the association between systemic inflammation and worse cognitive outcomes may be explained by: (a) pro‐inflammatory consequences of poor health behaviors (low physical activity, alcohol use, smoking) and/or (b) shared pathways between poor health behaviors and cognitive impairment. Our findings are consistent with a randomized trial that demonstrated that multi‐domain interventions---where exercise was a key component---resulted in cognitive benefits in older people.[27](#agm212044-bib-0027){ref-type="ref"} Furthermore, exercise has been associated with larger hippocampal volumes, increased gadolinium perfusion, and improved complex object recognition.[28](#agm212044-bib-0028){ref-type="ref"} Exercise is likely to be beneficial in reducing the vascular contributions to cognitive impairment from metabolic abnormalities, such as insulin resistance.

Despite these findings in the general population, there remains a case for investigating the relationship between systemic inflammation and neurodegeneration. Firstly, a wider panel of serum markers across the inflammatory cascade requires more detailed examination. Blood‐brain barrier dynamics linking serum and CNS inflammation also merits study, perhaps in the context of acute illnesses, such as delirium. Such a paradigm would investigate if different inflammatory burdens during acute illnesses contribute differently towards mechanisms in delirium and dementia and hence, variable dementia risks.[29](#agm212044-bib-0029){ref-type="ref"} An understanding of how systemic inflammation contributes to neurodegeneration, and their relation to already identified life course risk factors, might therefore implicate novel pathways towards modification of the course of Alzheimer\'s disease and other dementias.
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